ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,228, issued on June 24, was assigned to Innate Tumor Immunity Inc. (Princeton, N.J.).
"NLRP3 modulators" was invented by Scott Hunter Watterson (Pennington, N.J.), Daniel O'Malley (New Hope, Pa.), Ashvinikumar V. Gavai (Princeton Junction, N.J.), Patrice Gill (Levittown, Pa.), Steven P. Seitz (Swarthmore, Pa.) and Hua Gong (King of Prussia, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of Formula (I), (II) or (III): (I), (II), (III), wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, s...